PLoS Neglected Tropical Diseases (Jun 2022)

Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.

  • Diego Lins Guedes,
  • Elis Dionísio da Silva,
  • Maria Carolina Accioly Brelaz Castro,
  • Walter Lins Barbosa Júnior,
  • Ana Victoria Ibarra-Meneses,
  • Achilleas Tsoumanis,
  • Wim Adriaensen,
  • Johan van Griensven,
  • Valéria Rêgo Alves Pereira,
  • Zulma Maria de Medeiros

DOI
https://doi.org/10.1371/journal.pntd.0010542
Journal volume & issue
Vol. 16, no. 6
p. e0010542

Abstract

Read online

BackgroundVisceral leishmaniasis (VL) remains an important infectious disease worldwide. VL-HIV coinfected individuals can present with atypical clinical forms of VL and have a high risk of VL relapse. Some cytokines have been described as potential markers to diagnose active VL and to predict the severity of the cases. However, few studies have included VL-HIV coinfected patients. We aimed to characterize the levels of several cytokines among VL-HIV coinfected individuals living in a VL-endemic area in Northeast Brazil.MethodsThis was a retrospective, cross-sectional study, aiming to estimate the levels of various cytokines in symptomatic and asymptomatic VL-HIV coinfected individuals. There were 134 study participants (35 symptomatic VL-HIV, 75 asymptomatic VL-HIV, and 24 healthy controls), all ≥ 18 years-old. Serum cytokine levels (interferon-γ, tumor necrosis factor, and interleukins 2, 4, 6, 10, and 17A) were quantified using the Becton Dickinson-BD's Cytometric Bead Array (CBA) system.ResultsThe population mainly consisted of men (64.9%), with a median age of 35 (27-41) years. Asymptomatic individuals were younger (p = 0.013), with more years of education (p ConclusionsHigher serum levels of IL-17A, IL-6, and IL-10 cytokines were observed in symptomatic coinfected individuals but not in asymptomatically infected individuals. More studies among HIV-positive persons are needed to better understand the role of serum cytokines for prognosis, to define cure and predict VL relapses in VL-HIV coinfected individuals.